Literature DB >> 12728713

Generating human osteoclasts from peripheral blood.

Afsie Sabokbar1, Nicholas S Athanasou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12728713     DOI： 10.1385/1-59259-366-6:101

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  7 in total

1.  Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.

Authors:  Philippe M Campeau; James T Lu; Gautam Sule; Ming-Ming Jiang; Yangjin Bae; Simran Madan; Wolfgang Högler; Nicholas J Shaw; Steven Mumm; Richard A Gibbs; Michael P Whyte; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-08-08       Impact factor: 6.150

2.  Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.

Authors:  Qu Cui; Hironobu Shibata; Asuka Oda; Hiroe Amou; Ayako Nakano; Kenichiro Yata; Masahiro Hiasa; Keiichiro Watanabe; Shingen Nakamura; Hirokazu Miki; Takeshi Harada; Shiro Fujii; Kumiko Kagawa; Kyoko Takeuchi; Shuji Ozaki; Toshio Matsumoto; Masahiro Abe
Journal:  Int J Hematol       Date:  2011-06-23       Impact factor: 2.490

3.  Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma.

Authors:  Ken-Ichi Kitazoe; Masahiro Abe; Masahiro Hiasa; Asuka Oda; Hiroe Amou; Takeshi Harada; Ayako Nakano; Kyoko Takeuchi; Toshihiro Hashimoto; Shuji Ozaki; Toshio Matsumoto
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

4.  A novel assay for analysis of the regulation of the function of human osteoclasts.

Authors:  Barrie Kirstein; Urszula Grabowska; Bertil Samuelsson; Masahiro Shiroo; Timothy J Chambers; Karen Fuller
Journal:  J Transl Med       Date:  2006-11-07       Impact factor: 5.531

5.  Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.

Authors:  Orsolya Tünde Kovács; Eszter Tóth; Olivér Ozohanics; Eszter Soltész-Katona; Nikolett Marton; Edit Irén Buzás; László Hunyady; László Drahos; Gábor Turu; György Nagy
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

6.  Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.

Authors:  G Mabilleau; N L Petrova; M E Edmonds; A Sabokbar
Journal:  Diabetologia       Date:  2008-04-04       Impact factor: 10.122

7.  TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.

Authors:  David J Mahoney; Katalin Mikecz; Tariq Ali; Guillaume Mabilleau; Dafna Benayahu; Anna Plaas; Caroline M Milner; Anthony J Day; Afsaneh Sabokbar
Journal:  J Biol Chem       Date:  2008-06-26       Impact factor: 5.157
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.